| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: RIBX |
| Security Type |
Common Stock |
| Lead Underwriter |
Deutsche Bank Securities Corp |
| Days In Registration |
378 |
| Date Filed |
25-Nov-2011 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Rib-X Pharmaceuticals Inc, headquartered in New Haven, Connecticut, manufactures novel classes of antibiotics. It also provides small molecule drug discovery services. The company was founded in 2000. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
19.9M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
